This inventor holds 1 USPTO granted patent. Top assignee: Armel S.a.. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: Innovations of Jean M Sabatier in HIV Therapy
Introduction
Jean M Sabatier is a notable inventor based in Chateauneuf de Rouge, France. He has made significant contributions to the field of biomedical research, particularly in the development of therapeutic solutions for HIV. His innovative work focuses on peptide constructions that aim to combat the effects of this virus.
Latest Patents
Jean M Sabatier holds a patent for "Multiple branch peptide constructions for use against HIV." This invention teaches the creation of multiple branch peptide constructions (MBPCs) formed from a core matrix. These MBPCs are attached to peptides derived from the V3 loop of the envelope glycoprotein of HIV-1, including the amino acid sequence GPGR (SEQ ID NO: 5). The preferred form is GPGRAF, while avoiding the sequences IGPGR (SEQ ID NO: 1) or IXXGPGR (SEQ ID NO: 3). The MBPCs serve as a therapy against HIV by preventing virus/cell infection and cell-to-cell virus transmission between CD4+ cells and HIV. Importantly, these constructions do not hinder the immunogenic role of CD4+ cells and are effective in blocking CD4 receptors on lymphocytes and macrophages, as well as GalCer receptors on colon epithelial cells. The MBPCs are non-immunogenic and non-toxic at therapeutic doses, making them suitable for clinical use.
Career Highlights
Jean M Sabatier is associated with Armel S.A., where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on HIV treatment and prevention.
Collaborations
He collaborates with notable colleagues such as Emmanuel Fenouillet and Nouara Yahi, contributing to a dynamic research environment focused on innovative solutions for health challenges.
Conclusion
Jean M Sabatier's contributions to HIV therapy through his patented peptide constructions highlight the importance of innovation in medical research. His work exemplifies the potential for scientific advancements to improve health outcomes for individuals affected by HIV.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile